Melanoma Research Review, Issue 4

In this Issue:

ESMO Clinical Practice Guidelines on cutaneous melanoma
BRAF mutations in primary melanoma and rate of growth and survival
Citrus consumption and risk of cutaneous malignant melanoma
Long-term follow-up of melanoma patients treated with adjuvant radiotherapy after lymphadenectomy
NIVO given sequentially with IPI in patients with advanced melanoma
Efficacy and safety in melanoma patient subgroups of NIVO alone or combined with IPI versus IPI alone
Two-year estimate of overall survival in COMBI-v trial
T-VEC treatment for patients with advanced melanoma
T-VEC and pembrolizumab for unresectable stage IIIB-IV melanoma
Trametinib in metastatic melanoma containing BRAF kinase fusion

Please login below to download this issue (PDF)

Subscribe